Evidence map›Paper›PMID 39622574›Full record

Trial reportBMJ open2024

CATHETER II: a randomised controlled trial comparing the clinical effectiveness of various washout policies versus no washout policy in preventing catheter-associated complications in adults living with long-term catheters.

Mohamed Abdel-Fattah, Muhammad Imran Omar, Diana Johnson, David Cooper, Lynda Constable, Sheela Tripathee, Sara J MacLennan, Konstantinos Dimitropoulos, Suzanne Evans, Hashim Hashim and 14 more

Abstract readRandomized Controlled TrialComparative StudyEquivalence Trial
In one paragraph

Trial report in BMJ open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Mohamed Abdel-FattahAberdeen Centre for Women's Health Research, University of Aberdeen, Aberdeen, UK m.abdelfattah@abdn.ac.uk.
Muhammad Imran OmarAcademic Urology Unit, University of Aberdeen, Aberdeen, UK.ORCID http://orcid.org/0000-0002-1597-3126
Diana JohnsonCentre for Healthcare Randomised Trials, University of Aberdeen, Aberdeen, UK.ORCID http://orcid.org/0000-0003-0479-1228
David CooperCentre for Healthcare Randomised Trials, University of Aberdeen, Aberdeen, UK.ORCID http://orcid.org/0000-0002-9361-4399
Lynda ConstableCentre for Healthcare Randomised Trials, University of Aberdeen, Aberdeen, UK.
Sheela TripatheeAcademic Urology Unit, University of Aberdeen, Aberdeen, UK.ORCID http://orcid.org/0000-0003-1280-1406
Sara J MacLennanAcademic Urology Unit, University of Aberdeen, Aberdeen, UK.
Konstantinos DimitropoulosDepartment of Urology, Aberdeen Royal Infirmary, NHS Grampian, Aberdeen, UK.
Suzanne EvansBladder Health UK, Birmingham, UK.
Hashim HashimBristol Urological Institute, North Bristol NHS Trust, Bristol, UK.ORCID http://orcid.org/0000-0003-2467-407X
Mary KilonzoHealth Economics Research Unit, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK.
James LarcombeNHS Durham Dales Easington and Sedgefield CCG, Sedgefield, UK.ORCID http://orcid.org/0000-0002-3111-7346
Paul LittlePrimary Care Research Centre, University of Southampton, Southampton, UK.ORCID http://orcid.org/0000-0003-3664-1873
Peter MurchieAcademic Primary Care Research Group, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK.ORCID http://orcid.org/0000-0001-9968-5991
Phyo Kyaw MyintInstitute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK.ORCID http://orcid.org/0000-0003-3852-6158
James N'DowAcademic Urology Unit, University of Aberdeen, Aberdeen, UK.
Catherine PatersonSchool of Nursing, Midwifery and Public Health, University of Canberra, Canberra, Australian Capital Territory, Australia.ORCID http://orcid.org/0000-0002-1249-6782
Karen PowellBladder Health UK, Birmingham, UK.
Graham ScotlandHealth Economics Research Unit, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK.
Nikesh ThiruchelvamCambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Amanda YoungQueen's Nursing Institute, London, UK.ORCID http://orcid.org/0009-0009-9427-4697
Seonaidh CottonCentre for Healthcare Randomised Trials, University of Aberdeen, Aberdeen, UK.
John NorrieCentre for Public Health, Queen's University Belfast, Belfast, UK.ORCID http://orcid.org/0000-0001-9823-9252
Graeme MacLennanCentre for Healthcare Randomised Trials, University of Aberdeen, Aberdeen, UK.ORCID http://orcid.org/0000-0002-1039-5646

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesDo weekly prophylactic saline or acidic catheter washouts in addition to standard long-term catheter (LTC) care improve the outcomes of adults with LTC compared with standard LTC care only.

designThree-arm superiority open-label randomised controlled trial.

settingUK community-based study.

participants80 adults with LTC (any type/route) ≥28 days in situ with no plans to discontinue and able to self-manage the washouts/study documentation with/without a carer.

interventionsRandomly allocated (26:27:27) to receive standard LTC care with weekly saline or weekly acidic or no prophylactic washouts for up to 24 months. PRIMARY AND SECONDARY OUTCOME MEASURES: The primary outcome was catheter blockage requiring intervention (per 1000 catheter days). Secondary outcomes were symptomatic catheter-associated urinary tract infection (S-CAUTI) requiring antibiotics, adverse events, participants' quality of life and day-to-day activities, acceptability and adherence.

resultsOutcomes reported for 25 saline, 27 acidic and 26 control participants. LTC blockages (per 1000 catheter days) requiring treatment were 9.96, 10.53 and 20.92 in the saline, acidic and control groups, respectively. The incident rate ratio (IRR) favours the washout groups (saline 0.65 (97.5% CI 0.24 to 1.77); p=0.33 and acidic 0.59 (97.5% CI 0.22 to 1.63); p=0.25), although not statistically significant. The S-CAUTI rate (per 1000 catheter days) was 3.71, 6.72 and 8.05 in the saline, acidic and control groups, respectively. The IRR favours the saline group (saline 0.40 (97.5% CI 0.20 to 0.80); p=0.003 and acidic 0.98 (97.5% CI 0.54 to 1.78); p=0.93). The trial closed before reaching target recruitment due to reduced research capacity during the COVID-19 pandemic.

conclusionsEarly closure and small sample size limits our ability to provide a definite answer. However, the observed non-statistically significant differences over control are favourable for lower rates of LTC blockages without a concomitant rise in S-CAUTI. The results support a multinational randomised controlled trial of catheter washouts in patients with LTC to ascertain their clinical and cost-effectiveness. TRIAL REGISTRATION NUMBER: ISRCTN17116445.

Indexed as

Catheter-Related InfectionsAdultAgedCatheters, IndwellingFemaleHumansMaleMiddle AgedQuality of LifeSaline SolutionUnited KingdomUrinary CatheterizationUrinary Tract InfectionsSaline Solutionclinical trialurinary incontinencesurinary tract infectionsurology

Identifiers

PMID39622574
PMCPMC11624782

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.